Playing Through the Pain of Ulcerative Colitis
Two-time Olympian and former professional soccer player Rosie White shares how she overcame ulcerative colitis on and off the field. (Source: WebMD Health)
Source: WebMD Health - July 28, 2023 Category: Consumer Health News Source Type: news
Nearly 1 in 100 People Diagnosed With IBD in the US Nearly 1 in 100 People Diagnosed With IBD in the US
The most comprehensive study to date suggests an estimated 2.4 million Americans have clinically diagnosed inflammatory bowel disease, and up to 56,000 new cases are diagnosed each year.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 28, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Incidence of IBD 10.9 Per 100,000 Person-Years in the United States
TUESDAY, July 25, 2023 -- The incidence of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years and prevalence is 721 per 100,000 population, according to a study published online July 20 in Gastroenterology.
James D. Lewis, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 25, 2023 Category: Pharmaceuticals Source Type: news
Immunomodulators Increase Cervical Neoplasia Risk in IBD Immunomodulators Increase Cervical Neoplasia Risk in IBD
This study aimed to determine whether exposure to immunomodulators and/or biologics increase the risk of CIN2+ in women with inflammatory bowel disease.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 25, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
TNF Blockers for IBD Tied to Risk for Immune-Mediated Diseases
(MedPage Today) -- Treating inflammatory bowel disease (IBD) with tumor necrosis factor (TNF) inhibitors was paradoxically associated with an increased risk for other immune-mediated inflammatory diseases (IMIDs) in a large national study.
The... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - July 22, 2023 Category: Dermatology Source Type: news
New Drug Could Boost Outcomes for People With Ulcerative Colitis
TUESDAY, July 18, 2023 -- People living with the pain, bloody diarrhea and sometimes urgent need to use the toilet that comes with ulcerative colitis may soon have a new treatment option that ’s already been given the go-ahead in Europe.
The drug... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 18, 2023 Category: General Medicine Source Type: news
New Drug Awaiting FDA Approval, Omvoh, Could Boost Outcomes for People With Ulcerative Colitis
TUESDAY, July 18, 2023 -- People living with the pain, bloody diarrhea and sometimes urgent need to use the toilet that comes with ulcerative colitis may soon have a new treatment option that’s already been given the go-ahead in Europe.
The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 18, 2023 Category: General Medicine Source Type: news
One Type of Bariatric Surgery Betters IBD Outcomes One Type of Bariatric Surgery Betters IBD Outcomes
In people with morbid obesity and inflammatory bowel disease (IBD), sleeve gastrectomy and not Roux-en-Y gastric bypass was associated with a lower risk for complications 2 years later.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 13, 2023 Category: Surgery Tags: Gastroenterology News Source Type: news
Mirikizumab for UC: Phase 3 Data Now Published in NEJM Mirikizumab for UC: Phase 3 Data Now Published in NEJM
Mirikizumab manufacturer Eli Lilly, which funded the study, is hoping the drug will become the first IL-23 inhibitor to be approved in the United States for the treatment of ulcerative colitis (UC).MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 13, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
‘ Forever Chemical ’ Lawsuits Could Ultimately Eclipse the Big Tobacco Settlement
It was the dead cows on Wilbur Tennant’s farm that shaped most of Rob Bilott’s professional life. Tennant’s farm was located in Parkersburg, W. Va.; Bilott was—and remains—an environmental lawyer at the firm of Taft Stettinius & Hollister in Cincinnati. All had been well for Tennant until 1998, when half of his herd of 300 cows began to languish and die. The farmer and the lawyer never would have come together, but Bilott’s grandmother lived near Tennant, and a mutual friend suggested Tennant call her grandson for counsel.
Tennant had reason to suspect he needed the help of an envir...
Source: TIME: Science - July 12, 2023 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized Environment healthscienceclimate Source Type: news
‘Nocturnal diarrhoea’ could be a sign of inflammatory bowel disease - doctor explains
When there's a presence of "nocturnal diarrhoea", which means you wake up from a slumber to evacuate the bowels, then it's a sign of infection or an inflammatory disease, according to Dr Will Bulsiewicz. (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2023 Category: Consumer Health News Source Type: news
Aurobindo Pharma subsidiary enters pact with BioFactura for biosimilar ustekinumab
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma said it has entered into an exclusive license agreement with the US-based BioFactura to commercialize BFI-751, a proposed biosimilar to Stelara (ustekinumab). Ustekinumab is used for treating Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2023 Category: Pharmaceuticals Source Type: news
Psoriasis drug that is winning the war on Crohn's disease
The drug works by blocking immune cells that drive the serious bowel damage caused by Crohn's, and offers a much-needed option for patients who don't respond to current treatments. (Source: the Mail online | Health)
Source: the Mail online | Health - July 8, 2023 Category: Consumer Health News Source Type: news
Mirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
FRIDAY, July 7, 2023 -- For patients with moderately-to-severely active ulcerative colitis, mirikizumab is more effective than placebo for inducing and maintaining clinical remission, according to a study published in the June 29 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2023 Category: Pharmaceuticals Source Type: news
How Can Ulcerative Colitis Affect Your Cholesterol? How Can Ulcerative Colitis Affect Your Cholesterol?
A new study from researchers in the Netherlands found that IBD patients ' cardiovascular risk factors may be underestimated because of the absence of things like high cholesterol.WebMD Health News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 29, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
